Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
If your headaches are persistent or severe, speak to your prescriber
Li Y, Xiao W, Xiao K, Berti L, Luo J, Tseng HP, et al
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Take a look
MT-II itself has no regulatory approval for any indication and is not the same molecule as the approved bremelanotide product
Together, lets make informed choices that enhance our wellness journey and embrace healthier skin!
